Tarfah Al‐Warhi

2.2k citations

59 papers · 1.8k indexed · h-index 25

Organic Chemistry top 2%
Molecular Biology top 10%
Oncology
Pharmacology top 5%
Computational Theory and Mathematics top 5%

Co-authors: Wagdy M. Eldehna Hatem A. Abdel‐Aziz Eslam B. Elkaeed Ahmed Sabt Sara T. Al‐Rashood Ohoud J. Alotaibi Mahmoud A. El Hassab Ayman El‐Faham
Topics: Synthesis and biological activity (27 papers)Synthesis and Characterization of Heterocyclic Compounds (12 papers)Cancer therapeutics and mechanisms (11 papers)
Cited by: Organic Chemistry Toxicology Molecular Biology
Journals: Scientific Reports Journal of Medicinal Chemistry Molecules
Partner nations: Saudi Arabia Egypt United Kingdom

In The Last Decade

Tarfah Al‐Warhi

59 papers receiving 1.8k citations

Peers

Countries citing papers authored by Tarfah Al‐Warhi

Since Specialization

Citations

This map shows the geographic impact of Tarfah Al‐Warhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarfah Al‐Warhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarfah Al‐Warhi more than expected).

Fields of papers citing papers by Tarfah Al‐Warhi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tarfah Al‐Warhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarfah Al‐Warhi. The network helps show where Tarfah Al‐Warhi may publish in the future.

Co-authorship network of co-authors of Tarfah Al‐Warhi

This figure shows the co-authorship network connecting the top 25 collaborators of Tarfah Al‐Warhi. A scholar is included among the top collaborators of Tarfah Al‐Warhi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tarfah Al‐Warhi. Tarfah Al‐Warhi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Benzenesulfonohydrazide-tethered non-fused and fused heterocycles as potential anti-mycobacterial agents targeting enoyl acyl carrier protein reductase (InhA) with antibiofilm activity 2024 ·RSC Advances ·Tarfah Al‐Warhi,Ahmed Sabt,Małgorzata Korycka‐Machała,Asmaa F. Kassem,Moataz A. Shaldam,(unknown),(unknown),Bożena Dziadek,(unknown),Wagdy M. Eldehna,Jarosław Dziadek	5
2	Development of new LSM-83177 analogues as anti-tumor agents against colorectal cancer targeting p53-MDM2 interaction 2024 ·Bioorganic Chemistry ·(unknown),(unknown),Tarfah Al‐Warhi,Wagdy M. Eldehna,Hatem A. Abdel‐Aziz	9
3	1,2,4-Triazole-Tethered Indolinones as New Cancer-Fighting Small Molecules Targeting VEGFR-2: Synthesis, Biological Evaluations and Molecular Docking 2024 ·Pharmaceuticals ·(unknown),(unknown),(unknown),Tarfah Al‐Warhi,(unknown),Wagdy M. Eldehna	9
4	Design and synthesis of benzo[b]thiophene‐based hybrids as novel antitubercular agents against MDR/XDR Mycobacterium tuberculosis 2023 ·Archiv der Pharmazie ·Tarfah Al‐Warhi,(unknown),Hadia Almahli,Marwa M. Abdel‐Aziz,Zainab M. Elsayed,(unknown),Wagdy M. Eldehna	3
5	Design and synthesis of novel rigid dibenzo[ b,f ]azepines through ring closure technique as promising anticancer candidates against leukaemia and acting as selective topoisomerase II inhibitors and DNA intercalators 2023 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Mohammed Farrag El‐Behairy,(unknown),Mohamed M. Khalifa,Mohamed S. Nafie,Mohamed A. Saleh,Mohammed S. Abdel‐Maksoud,Tarfah Al‐Warhi,Wagdy M. Eldehna,Ahmed A. Al‐Karmalawy	19
6	Chemical composition, seasonal variation and antiaging activities of essential oil from Callistemon subulatus leaves growing in Egypt 2023 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·(unknown),Heba A. S. El‐Nashar,Taghreed A. Majrashi,Tarfah Al‐Warhi,Mahmoud A. El Hassab,Wagdy M. Eldehna,Nada M. Mostafa	27
7	Identification of novel ureido benzothiophenes as dual VEGFR-2/EGFR anticancer agents 2023 ·Bioorganic Chemistry ·Wagdy M. Eldehna,Ghada H. Al-Ansary,Tarfah Al‐Warhi,(unknown),Mahmoud M. Elaasser,(unknown)	13
8	1-Benzyl-5-bromo-3-hydrazonoindolin-2-ones as Novel Anticancer Agents: Synthesis, Biological Evaluation and Molecular Modeling Insights 2023 ·Molecules ·Tarfah Al‐Warhi,Hadia Almahli,(unknown),Zainab M. Elsayed,Mahmoud A. El Hassab,Ohoud J. Alotaibi,Nada Aljaeed,Rezk R. Ayyad,(unknown),Wagdy M. Eldehna,(unknown)	16
9	Antioxidant and Wound Healing Potential of Vitis vinifera Seeds Supported by Phytochemical Characterization and Docking Studies 2022 ·Antioxidants ·Tarfah Al‐Warhi,Eman Maher Zahran,Samy Selim,Mohammad M. Al‐Sanea,Mohammed M. Ghoneim,(unknown),Yaser A. Mostafa,Faisal Alsenani,Mahmoud A. Elrehany,Mohammed S. Almuhayawi,Soad K. Al Jaouni,Usama Ramadan Abdelmohsen,Abeer H. Elmaidomy	42
10	Design, Synthesis, and Investigation of Cytotoxic Activity of cis-Vinylamide-Linked Combretastatin Analogues as Potential Anticancer Agents 2022 ·Symmetry ·Tarfah Al‐Warhi,Leena S. Alqahtani,(unknown),Matokah M. Abualnaja,Ola A. Abu Ali,Safa H. Qahl,(unknown),(unknown),(unknown),Fahmy G. Elsaid,Ali A. Shati,Salman Aloufi,Eman Fayad,Islam Zaki,(unknown)	9
11	Enaminone-based carboxylic acids as novel non-classical carbonic anhydrases inhibitors: design, synthesis and in vitro biological assessment 2022 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Mahmoud F. Abo-Ashour,Hadia Almahli,Alessandro Bonardi,(unknown),Tarfah Al‐Warhi,Sara T. Al‐Rashood,Hatem A. Abdel‐Aziz,Alessio Nocentini,Claudiu T. Supuran,Wagdy M. Eldehna	13
12	Bioactive Phytochemicals of Citrus reticulata Seeds—An Example of Waste Product Rich in Healthy Skin Promoting Agents 2022 ·Antioxidants ·Tarfah Al‐Warhi,Abeer H. Elmaidomy,Samy Selim,Mohammad M. Al‐Sanea,Mha Albqmi,Ehab M. Mostafa,(unknown),Mohammed M. Ghoneim,Ahmed M. Sayed,Usama Ramadan Abdelmohsen	11
13	The Wound-Healing Potential of Olea europaea L. Cv. Arbequina Leaves Extract: An Integrated In Vitro, In Silico, and In Vivo Investigation 2022 ·Metabolites ·Tarfah Al‐Warhi,Abeer H. Elmaidomy,(unknown),(unknown),Samy Selim,Mha Albqmi,Mohammad M. Al‐Sanea,Taghreed S. Alnusaire,Mohammed M. Ghoneim,Ehab M. Mostafa,(unknown),Ashraf K. El‐Damasy,(unknown),Mahmoud A. Elrehany,Ahmed M. Sayed,Eman M. Othman,Mohamed El‐Sherbiny,Usama Ramadan Abdelmohsen	20
14	GC-MS metabolites profiling of anethole-rich oils by different extraction techniques: antioxidant, cytotoxicity and in-silico enzymes inhibitory insights 2022 ·Journal of Enzyme Inhibition and Medicinal Chemistry ·Dina M. El‐Kersh,Nada M. Mostafa,Shaimaa Fayez,Tarfah Al‐Warhi,Mohammed A. S. Abourehab,Wagdy M. Eldehna,Mohamed A. Salem	17
15	Design, synthesis, in vitro biological assessment and molecular modeling insights for novel 3-(naphthalen-1-yl)-4,5-dihydropyrazoles as anticancer agents with potential EGFR inhibitory activity 2022 ·Scientific Reports ·Wagdy M. Eldehna,Mahmoud A. El Hassab,Zainab M. Elsayed,Tarfah Al‐Warhi,Hazem Elkady,Mahmoud F. Abo-Ashour,Mohammed A. S. Abourehab,Ibrahim H. Eissa,Hatem A. Abdel‐Aziz	57
16	Strawberry and Ginger Silver Nanoparticles as Potential Inhibitors for SARS-CoV-2 Assisted by In Silico Modeling and Metabolic Profiling 2021 ·Antibiotics ·Mohammad M. Al‐Sanea,(unknown),Mohamed A. Abdelgawad,Arafa Musa,Mohammed M. Ghoneim,Tarfah Al‐Warhi,Nada Aljaeed,Ohoud J. Alotaibi,Taghreed S. Alnusaire,Sayed F. Abdelwahab,(unknown),Usama Ramadan Abdelmohsen,Khayrya A. Youssif	37
17	Development of isatin-thiazolo[3,2-a]benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological and molecular dynamics investigations 2021 ·Bioorganic Chemistry ·Wagdy M. Eldehna,Mahmoud A. El Hassab,Mahmoud F. Abo-Ashour,Tarfah Al‐Warhi,Mahmoud M. Elaasser,Nesreen A. Safwat,(unknown),Marwa F. Ahmed,Sara T. Al‐Rashood,Hatem A. Abdel‐Aziz,Radwan El‐Haggar	80
18	Benzofuran-Based Carboxylic Acids as Carbonic Anhydrase Inhibitors and Antiproliferative Agents against Breast Cancer 2020 ·ACS Medicinal Chemistry Letters ·Wagdy M. Eldehna,Alessio Nocentini,Zainab M. Elsayed,Tarfah Al‐Warhi,Nada Aljaeed,Ohoud J. Alotaibi,Mohammad M. Al‐Sanea,Hatem A. Abdel‐Aziz,Claudiu T. Supuran	55
19	Recent advancements of coumarin-based anticancer agents: An up-to-date review 2020 ·Bioorganic Chemistry ·Tarfah Al‐Warhi,Ahmed Sabt,Eslam B. Elkaeed,Wagdy M. Eldehna	166
20	3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and molecular modeling studies 2020 ·European Journal of Medicinal Chemistry ·Abdulsalam A. M. Alkhaldi,Mohammad M. Al‐Sanea,Alessio Nocentini,Wagdy M. Eldehna,Zainab M. Elsayed,Alessandro Bonardi,Mahmoud F. Abo-Ashour,Ashraf K. El‐Damasy,Mohammed S. Abdel‐Maksoud,Tarfah Al‐Warhi,Paola Gratteri,Hatem A. Abdel‐Aziz,Claudiu T. Supuran,Radwan El‐Haggar	62

About Tarfah Al‐Warhi

Tarfah Al‐Warhi is a scholar working on Organic Chemistry, Toxicology and Biochemistry, having authored 59 papers that have together received 1.8k indexed citations. Recurring topics across this work include Synthesis and biological activity (27 papers), Synthesis and Characterization of Heterocyclic Compounds (12 papers) and Cancer therapeutics and mechanisms (11 papers). The work is most often cited by research in Organic Chemistry (1.1k citations), Toxicology (115 citations) and Molecular Biology (802 citations). Tarfah Al‐Warhi has collaborated with scholars based in Saudi Arabia, Egypt and United Kingdom. Frequent co-authors include Wagdy M. Eldehna, Hatem A. Abdel‐Aziz, Eslam B. Elkaeed, Ahmed Sabt, Sara T. Al‐Rashood, Ohoud J. Alotaibi, Mahmoud A. El Hassab, Ayman El‐Faham, Nada Aljaeed and Zainab M. Elsayed. Their work appears in journals such as Scientific Reports, Journal of Medicinal Chemistry and Molecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact